<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方Pro | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-23T23:26:46+08:00</updated>
  <subtitle>聚焦生物医药前沿，洞察研发投资风向</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>总生存率最高提升至80%！CRISPR抗癌获突破：新型给药系统安全有效，体内编辑率高达80% | Science子刊</title>
    <updated>2020-11-23T20:58:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/6vzDNCBdhnXbqEINKC_irA</id>
    <link href="https://mp.weixin.qq.com/s/6vzDNCBdhnXbqEINKC_irA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>胰腺癌新靶点——NetG1</title>
    <updated>2020-11-22T21:00:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/robqQfFehFVuiZmjiq3Vjw</id>
    <link href="https://mp.weixin.qq.com/s/robqQfFehFVuiZmjiq3Vjw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Nature：PROTAC之后，又一种蛋白降解剂来了……</title>
    <updated>2020-11-21T20:59:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-21:/s/D3huhs9aSAwxuFjdBM_47Q</id>
    <link href="https://mp.weixin.qq.com/s/D3huhs9aSAwxuFjdBM_47Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>开发表观遗传修饰酶靶向疗法！Imago完成8000万美元C轮融资，目标是变革血癌治疗</title>
    <updated>2020-11-20T21:00:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/da4sK2rifPuHUF2psKEcRQ</id>
    <link href="https://mp.weixin.qq.com/s/da4sK2rifPuHUF2psKEcRQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>BTK抑制剂「图鉴」</title>
    <updated>2020-11-19T21:17:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/CFeXyVy-M4rVWIlhZcBibw</id>
    <link href="https://mp.weixin.qq.com/s/CFeXyVy-M4rVWIlhZcBibw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>iNKT细胞疗法“新兵”——双特异性抗体</title>
    <updated>2020-11-18T21:02:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/z9lZW1J3tWVfXvAZadUQrw</id>
    <link href="https://mp.weixin.qq.com/s/z9lZW1J3tWVfXvAZadUQrw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>突破给药途径局限！新型溶瘤病毒疗法：可静脉注射，让PD-1抗体疗效更出众</title>
    <updated>2020-11-17T21:01:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/yH0y8cTPmaVhmhqxn_fQqA</id>
    <link href="https://mp.weixin.qq.com/s/yH0y8cTPmaVhmhqxn_fQqA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>挑战三阴性乳腺癌！新型癌症疫苗：有效预防复发，100%小鼠存活 | Nature子刊</title>
    <updated>2020-11-16T21:02:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/JI_6n-sh7dl-kaTIzhVGYg</id>
    <link href="https://mp.weixin.qq.com/s/JI_6n-sh7dl-kaTIzhVGYg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PD-1抗体“新搭档”——iNK细胞疗法 | Science子刊最新成果</title>
    <updated>2020-11-15T20:59:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/ye5ksRw3Vq1oo8GULVpZWA</id>
    <link href="https://mp.weixin.qq.com/s/ye5ksRw3Vq1oo8GULVpZWA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>下一代癌症免疫疗法——CD25抗体 | Nature子刊最新成果</title>
    <updated>2020-11-14T21:00:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/Mep-kjJOqL_CQLJwkCXdPg</id>
    <link href="https://mp.weixin.qq.com/s/Mep-kjJOqL_CQLJwkCXdPg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>